{"slug":"tirzepatide-skin","verification":{"valid":true,"entries":2,"head":"90c1b565e630d532f66eade36b1d0808d5091e38e4c090609c44196b28a7715e"},"energy":{"passes":2,"tokens_in":17476,"tokens_out":4066,"tokens_total":21542,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"90c1b565e630d532f66eade36b1d0808d5091e38e4c090609c44196b28a7715e"},"provenance":[{"ts":"2026-06-29T22:39:02.380Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Tirzepatide for Skin\nSlug: tirzepatide-skin\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"tirzepatide\",\"name\":\"Tirzepatide\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"tirzepatide\",\"name\":\"Tirzepatide\",\"section_title\":\"Why Tirzepatide might help you\",\"layer\":\"metabolic load / body weight\",\"steps\":[\"**What keeps failing:** Same mechanical overload pattern as other GLP-1 contexts at higher body weight.\",\"**What Tirzepatide is studied to do:** Studied for GLP-1/GIP weight loss — load reduction on spine and joints.\",\"**Therefore for you:** If that layer is part of your problem, Tirzepatide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** Same mechanical overload pattern as other GLP-1 contexts at higher body weight.\\n2. **What Tirzepatide is studied to do:** Studied for GLP-1/GIP weight loss — load reduction on spine and joints.\\n3. **Therefore for you:** If that layer is part of your problem, Tirzepatide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile incl","response":"{\n  \"slug\": \"tirzepatide-skin\",\n  \"title\": \"Tirzepatide and Skin: Evidence on Weight-Loss Effects, Adverse Reactions, and Inflammatory Conditions\",\n  \"body\": \"## What's breaking down\\n\\nSkin health involves layers of structure and repair. Obesity stretches skin over time, reducing elasticity through changes in collagen and elastin. Rapid fat loss removes underlying support, leaving excess tissue that does not retract fully. Inflammatory skin diseases such as psoriasis or hidradenitis suppurativa can worsen with metabolic stress and excess weight. These processes reflect degeneration outpacing the skin's ability to maintain firmness and barrier function. Tirzepatide targets body weight and glucose control; any skin discussion centers on whether those changes support or challenge skin integrity.\\n\\n## Why Tirzepatide might help you\\n\\n1. What keeps failing: Excess body weight maintains mechanical stretch on skin while metabolic factors sustain low-grade inflammation that impairs collagen maintenance.\\n2. What Tirzepatide is studied to do: It activates GLP-1 and GIP pathways linked to substantial weight reduction (typically 15-20% body weight in trials) and improved glycemic control.\\n3. Therefore for you: If excess weight or related inflammation forms part of the skin issue, Tirzepatide is examined because it addresses the metabolic load layer through fat reduction rather than directly altering skin cells or masking symptoms.\\n\\nWeight loss of this magnitude decreases compressive forces on tissues overall. For skin specifically, less subcutaneous fat can reveal or accentuate laxity in areas previously supported by adipose tissue. The same pathway may lower systemic inflammation that contributes to certain dermatologic conditions.\\n\\n## How these fit together\\n\\nSingle-compound focus. Tirzepatide acts on the metabolic load and body weight layer. Any skin outcome—whether reduced inflammatory drive in conditions like psoriasis or increased laxity from rapid fat loss—stem","tokens_in":17476,"tokens_out":4066,"cost":0,"prev":"genesis","hash":"fa87b8ee6567bf33ed27812eded36383c200caffafc63d3fff5270100f33ce77"},{"ts":"2026-07-17T02:43:19.771Z","model":"owner","action":"voxel_divide","prompt":"","input":"tirzepatide-skin","response":"19 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"fa87b8ee6567bf33ed27812eded36383c200caffafc63d3fff5270100f33ce77","hash":"90c1b565e630d532f66eade36b1d0808d5091e38e4c090609c44196b28a7715e"}]}